Delivery Order SPE2DB24D9313-SPE2DB25FYBHM
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,424.46 by the Defense Logistics Agency on September 11, 2025, for the supply of Xolair 300 mg/2 mL auto-injector units. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 2, 2025, and no set-aside designation was applied to this procurement action. This delivery order is issued under...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $13,697.84 by the Defense Logistics Agency on April 24, 2025, for the supply of Xolair 300 mg/2 ml auto-injector medications. The delivery order, which carries no set-aside designation, is scheduled for completion by May 15, 2025, with performance occurring at the company's Park Ridge facility. This award represents a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency on September 9, 2025, for the supply of Xolair 300 mg/2 ml auto-injector vials. The contract has a ceiling value of $6,848.92 and is structured as a firm fixed-price delivery order with an ultimate completion date of September 30, 2025. No set-aside designation was applied to this award, and performance will take place...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,702.68 by the Defense Logistics Agency on September 3, 2025. The contract calls for the delivery of Xolair 75 mg/0.5 ml auto-injector syringes, with an ultimate completion date of September 24, 2025. This award was made without a set-aside designation, allowing the company to compete directly in the federal marketplace....
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 26, 2025, by the Defense Logistics Agency for Xolair 300 mg/2 ml auto-injector medications. The contract is valued at $1,712.23 with a firm fixed-price structure and no set-aside designation. The delivery order is set to be completed by September 17, 2025, and represents a single purchase under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on June 4, 2025, for the supply of Xolair 300 mg/2 mL auto-injector vials. This firm fixed-price delivery order, valued at $1,712.23, is set to be completed by June 26, 2025, with performance occurring at the vendor's facility in Park Ridge. The award does not utilize a set-aside designation, allowing DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $10,273.38 by the Defense Logistics Agency on August 15, 2025, for the supply of Xolair 300 mg/2 ml auto-injector vials. This firm fixed-price delivery order, with an ultimate completion date of September 8, 2025, carries no set-aside designation. The award represents a discrete fulfillment order issued under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for Xolair 300 mg/2 mL auto-injector vials valued at $3,424.46. The award, issued on September 3, 2025, with a completion date of September 24, 2025, represents a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group, based in Park Ridge, Illinois, will perform the delivery at its location. This delivery order falls...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,424.46 by the Defense Logistics Agency on April 24, 2025, for the supply of Xolair 300 mg/2 ml auto-injector units. The award utilizes a firm fixed-price contract type with no set-aside designation, with an ultimate completion date of May 15, 2025. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,424.46 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 ml auto-injector units. This firm fixed-price delivery order, issued on September 3, 2025, with completion targeted for September 24, 2025, represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The company,...
- SPE2DB24D9313Indefinite Delivery Contract
- SPE2DB24D9313-SPE2DB25FYBHMDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency on September 15, 2025, for Xolair 300 mg/2 ml auto-injector pharmaceutical products, with a ceiling value of $1,712.23. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The contract carries no set-aside designation, allowing the company to compete directly in the federal procurement marketplace. The place of performance is Park Ridge, Illinois, with an ultimate completion date of October 6, 2025. This delivery order represents a continuation of DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, providing prescription medications and medical supplies to Department of Defense healthcare facilities. The company has consistently secured pharmaceutical delivery orders from the Defense Logistics Agency covering an extensive portfolio of products including branded and generic prescription drugs, biologics, auto-injectors, and specialty medications. The firm fixed-price structure ensures cost predictability for the government while supporting military health facility supply needs across the defense healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/15/25 |